This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bourassa, M. G. Search for Related Content PubMed PubMed Citation Articles by Bourassa, M. G.

Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery?

The bypass angioplasty revascularization investigation (BARI)

Martial G. Bourassa, MD, FACC^a, Kevin E. Kip, PhD, Alice K. Jacobs, MD, FACC, Robert H. Jones, MD, FACC, George Sopko, MD^||, Allan D. Rosen, PhD, Barry L. Sharaf, MD, FACC^¶, Leonard Schwartz, MD, FACC^#, Bernard R. Chaitman, MD, FACC^**, Edwin L. Alderman, MD, FACC, David R. Holmes, MD, FACC, Gary S. Roubin, MD, PhD, FACC, Katherine M. Detre, MD, DR PH, FACC, Robert L. Frye, MD, FACC for the BARI Investigators

^a Department of Medicine, Montreal Heart Institute, Montreal, Canada
University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Boston Medical Center, Boston, Massachusetts, USA
Duke University Medical Center, Durham, North Carolina, USA
^|| NHLBI, Bethesda, Maryland, USA
^¶ Rhode Island Hospital, Providence, Rhode Island, USA
^# The Toronto Hospital, Toronto, Canada
^** St. Louis Hospital, St. Louis, Missouri, USA
Stanford University Medical Center, Palo Alto, California, USA
Mayo Clinic, Rochester, Minnesota, USA
Lenox Hills Hospital, New York, New York, USA

View larger version (23K): [in a new window]   Figure 1 Diagram of the Bypass Angioplasty Revascularization Investigation population showing the number of patients with complete revascularization (CR) versus incomplete revascularization (IR) intended (if assigned to percutaneous transluminal coronary angioplasty [PTCA]) and for each group, random assignment and actual treatment by coronary artery bypass graft surgery (CABG) or PTCA. *Refers to eligible patients who agreed to be randomized although the intended completeness of revascularization was assessed for all patients before study entry. **In 311 of the 624 patients clinically important lesions not intended for revascularization were involved.

View larger version (28K): [in a new window]   Figure 2 Angina status among percutaneous transluminal coronary angioplasty (PTCA) patients with complete revascularization (CR) versus incomplete revascularization (IR) intended. CCS = Canadian Cardiovascular Society.